134 related articles for article (PubMed ID: 28338654)
1. TFEB-VEGFA (6p21.1) co-amplified renal cell carcinoma: a distinct entity with potential implications for clinical management.
Gupta S; Johnson SH; Vasmatzis G; Porath B; Rustin JG; Rao P; Costello BA; Leibovich BC; Thompson RH; Cheville JC; Sukov WR
Mod Pathol; 2017 Jul; 30(7):998-1012. PubMed ID: 28338654
[TBL] [Abstract][Full Text] [Related]
2. A rare case of TFEB/6p21/VEGFA-amplified renal cell carcinoma diagnosed by whole-exome sequencing: clinicopathological and genetic feature report and literature review.
Zhang R; Ding M; Zhu X; Li X; Hu Q; Tao L; Hu W; Zou H
Diagn Pathol; 2024 May; 19(1):66. PubMed ID: 38730456
[TBL] [Abstract][Full Text] [Related]
3. Incidental Detection of
Repetto F; Sirohi D; Greipp P; Mahlow J
Int J Surg Pathol; 2024 May; 32(3):551-555. PubMed ID: 37394760
[No Abstract] [Full Text] [Related]
4. Prognosis and Clinicopathological Characters of Adult TFEB-Altered Renal Cell Carcinoma: A Single Center Experience of 18 Cases.
Wu J; Cao CZ; Cui HL; Du G; Shi HZ; Liang J; Guo L; Wang YC; Zhang J; Zhou AP; Li CL; Zheng S; Shou JZ
Clin Genitourin Cancer; 2024 Apr; 22(2):261-268.e3. PubMed ID: 38104031
[TBL] [Abstract][Full Text] [Related]
5. A
Smith SC; Yu J; Paul AK
Int J Surg Pathol; 2024 May; 32(3):539-542. PubMed ID: 37415407
[TBL] [Abstract][Full Text] [Related]
6. Metastatic Translocated Renal Cell Carcinoma in a Kidney Transplant Patient - a Case Report and Review of the Literature.
Kläger J; Schmidinger M; Oszwald A; Wasinger G; Fajkovic H; Compérat E
Int J Surg Pathol; 2024 May; 32(3):594-600. PubMed ID: 37415400
[No Abstract] [Full Text] [Related]
7. Primary, Metastatic Tumors Vary Genomically by Cancer Type.
Cancer Discov; 2023 Jul; 13(7):1505-1506. PubMed ID: 37249311
[TBL] [Abstract][Full Text] [Related]
8. InferAMP, a python web app for copy number inference from discrete gene-level amplification signals noted in clinical tumor profiling reports.
Kenny PA
F1000Res; 2019; 8():807. PubMed ID: 31608148
[TBL] [Abstract][Full Text] [Related]
9. VEGFA Status as a Predictive Marker of Therapy Outcome in Metastatic Gastric Cancer Patients Following Ramucirumab-Based Treatment.
Schirizzi A; Arshadi A; Tolomeo D; Schirosi L; Valentini AM; De Leonardis G; Refolo MG; Donghia R; Storlazzi CT; Zito A; Ricci AD; Vallarelli S; Ostuni C; Bencivenga M; De Manzoni G; Messa C; Armentano R; Giannelli G; Lotesoriere C; D'Alessandro R
Biomedicines; 2023 Oct; 11(10):. PubMed ID: 37893095
[TBL] [Abstract][Full Text] [Related]
10. The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma.
Ricketts CJ; De Cubas AA; Fan H; Smith CC; Lang M; Reznik E; Bowlby R; Gibb EA; Akbani R; Beroukhim R; Bottaro DP; Choueiri TK; Gibbs RA; Godwin AK; Haake S; Hakimi AA; Henske EP; Hsieh JJ; Ho TH; Kanchi RS; Krishnan B; Kwiatkowski DJ; Liu W; Merino MJ; Mills GB; Myers J; Nickerson ML; Reuter VE; Schmidt LS; Shelley CS; Shen H; Shuch B; Signoretti S; Srinivasan R; Tamboli P; Thomas G; Vincent BG; Vocke CD; Wheeler DA; Yang L; Kim WY; Robertson AG; ; Spellman PT; Rathmell WK; Linehan WM
Cell Rep; 2024 Apr; 43(4):113063. PubMed ID: 38578829
[No Abstract] [Full Text] [Related]
11. VEGFA amplification/increased gene copy number and VEGFA mRNA expression in renal cell carcinoma with TFEB gene alterations.
Caliò A; Brunelli M; Segala D; Pedron S; Doglioni C; Argani P; Martignoni G
Mod Pathol; 2019 Feb; 32(2):258-268. PubMed ID: 30206412
[TBL] [Abstract][Full Text] [Related]
12. TFEB Expression Profiling in Renal Cell Carcinomas: Clinicopathologic Correlations.
Gupta S; Argani P; Jungbluth AA; Chen YB; Tickoo SK; Fine SW; Gopalan A; Al-Ahmadie HA; Sirintrapun SJ; Sanchez A; Hakimi AA; Mcfarlane T; Salazar PA; Williamson SR; Skala SL; Mehra R; Hes O; Antonescu CR; Ladanyi M; Arcila ME; Reuter VE
Am J Surg Pathol; 2019 Nov; 43(11):1445-1461. PubMed ID: 31600176
[TBL] [Abstract][Full Text] [Related]
13. Detection of 6 TFEB-amplified renal cell carcinomas and 25 renal cell carcinomas with MITF translocations: systematic morphologic analysis of 85 cases evaluated by clinical TFE3 and TFEB FISH assays.
Skala SL; Xiao H; Udager AM; Dhanasekaran SM; Shukla S; Zhang Y; Landau C; Shao L; Roulston D; Wang L; Siddiqui J; Cao X; Magi-Galluzzi C; Zhang M; Osunkoya AO; Smith SC; McKenney JK; Betz BL; Myers JL; Chinnaiyan AM; Tomlins SA; Mehra R
Mod Pathol; 2018 Jan; 31(1):179-197. PubMed ID: 28840857
[TBL] [Abstract][Full Text] [Related]
14. TFEB rearranged renal cell carcinoma. A clinicopathologic and molecular study of 13 cases. Tumors harboring MALAT1-TFEB, ACTB-TFEB, and the novel NEAT1-TFEB translocations constantly express PDL1.
Caliò A; Harada S; Brunelli M; Pedron S; Segala D; Portillo SC; Magi-Galluzzi C; Netto GJ; Mackinnon AC; Martignoni G
Mod Pathol; 2021 Apr; 34(4):842-850. PubMed ID: 33208882
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive study of three novel cases of TFEB-amplified renal cell carcinoma and review of the literature: Evidence for a specific entity with poor outcome.
Mendel L; Ambrosetti D; Bodokh Y; Ngo-Mai M; Durand M; Simbsler-Michel C; Delhorbe M; Amiel J; Pedeutour F
Genes Chromosomes Cancer; 2018 Mar; 57(3):99-113. PubMed ID: 29127730
[TBL] [Abstract][Full Text] [Related]
16. [TFEB-amplified renal cell carcinoma. A case report and review of the literature].
Mayoral Guisado C; Gómez Durán Á; Agustín Benítez López D; Toro Zambrano W; Rubio Fernández A; Moreno Ontalba A; Díaz Delgado M
Rev Esp Patol; 2018; 51(4):248-252. PubMed ID: 30269777
[TBL] [Abstract][Full Text] [Related]
17. Clinical Relevance of Gene Copy Number Variation in Metastatic Clear Cell Renal Cell Carcinoma.
Nouhaud FX; Blanchard F; Sesboue R; Flaman JM; Sabourin JC; Pfister C; Di Fiore F
Clin Genitourin Cancer; 2018 Aug; 16(4):e795-e805. PubMed ID: 29548613
[TBL] [Abstract][Full Text] [Related]
18. Renal Neoplasia in Tuberous Sclerosis: A Study of 41 Patients.
Gupta S; Jimenez RE; Herrera-Hernandez L; Lohse CM; Thompson RH; Boorjian SA; Leibovich BC; Cheville JC
Mayo Clin Proc; 2021 Jun; 96(6):1470-1489. PubMed ID: 33526281
[TBL] [Abstract][Full Text] [Related]
19. Renal neoplasia with papillary architecture involving the pelvicalyceal system.
Gupta S; Cheville JC; Galeano BK; Sukov WR; Herrera-Hernandez L; Reed KA; Lohse CM; Thompson RH; Boorjian SA; Leibovich BC; Jimenez RE
Hum Pathol; 2021 Jan; 107():46-57. PubMed ID: 33166576
[TBL] [Abstract][Full Text] [Related]
20. Secondary renal neoplasia following chemotherapy or radiation in pediatric patients.
Gupta S; Vanderbilt CM; Leibovich BC; Herrera-Hernandez L; Raghunathan A; Sukov WR; Voss JS; Barr Fritcher EG; Reed KA; Lohse CM; Reuter VE; Jimenez RE; Thompson RH; Cheville JC
Hum Pathol; 2020 Sep; 103():1-13. PubMed ID: 32681944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]